Search
for
Sort by
Research 91–120 of 147
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Hormonal Therapy for Acne
- A cross-specialty expert opinion on the management of hair loss in gynaecological and endocrinological disorders in Indian patients
- Menopause in Women, Andropause in Men: Myth, Reality, and Management
- Pattern of Hyperandrogenemia in Patients with Polycystic Ovary Syndrome at a Tertiary Care Hospital
- Hirsutism due to polycystic ovarian syndrome: An integrative review of pathophysiology and management
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Androgen effects on the skin
- Hormonal Treatment for Skin Androgen-Related Disorders
- The acne hormones
- Frequency of polycystic ovarian syndrome in women with postadolescent acne
- General Characteristics of Hair in Eating Disorders
- The role of androgen and androgen receptor in skin-related disorders
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Hirsutism: diagnosis and treatment
- Androgenic Alopecia
- Is acne a sign of androgen excess disorder or not?
- Actualización del Síndrome de Ovario Poliquístico y su importancia en Dermatología
- Increasing of PCOs among Young Females
- Disorders of excessive hair growth in the adolescent
- Correlations between hormonal intrauterine devices and androgenic skin conditions: A retrospective cohort study
- androgenetic alopecia, n.
- Polycystic Ovary Syndrome
- Treatment options for polycystic ovary syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Progestogens with Antiandrogenic Properties